USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.24+0.51 (+4.01%)
Close on Nov 13, 2026Market cap $244.63MP/E –Yield –
USANA Health Sciences gross margin
Gross margin is gross profit as a percentage of revenue.
USANA Health Sciences's gross margin for the twelve months ending Oct 3, 2026 was 77.3%. For fiscal 2025 it was 78.3%, against 81.1% the year before. The highest annual figure on record is 83.1% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 78.3% | −2.8 |
| FY2024 | Dec 28, 2024 | 81.1% | +0.3 |
| FY2023 | Dec 30, 2023 | 80.8% | +0.2 |
| FY2022 | Dec 31, 2022 | 80.6% | −1.1 |
| FY2021 | Jan 1, 2022 | 81.6% | +0.1 |
| FY2020 | Jan 2, 2021 | 81.6% | −0.8 |
| FY2019 | Dec 28, 2019 | 82.3% | −0.8 |
| FY2018 | Dec 29, 2018 | 83.1% | +0.3 |
| FY2017 | Dec 30, 2017 | 82.9% | +0.8 |
| FY2016 | Dec 31, 2016 | 82.1% | −0.5 |
| FY2015 | Jan 2, 2016 | 82.6% | +0.4 |
| FY2014 | Jan 3, 2015 | 82.2% | −0.1 |
| FY2013 | Dec 28, 2013 | 82.3% | +0.1 |
| FY2012 | Dec 29, 2012 | 82.1% | −0.4 |
| FY2011 | Dec 31, 2011 | 82.5% | +1.0 |
| FY2010 | Jan 1, 2011 | 81.6% | +2.1 |
| FY2009 | Jan 2, 2010 | 79.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | 76.3% | −0.8 |
| Q2 FY2026 | Jul 4, 2026 | 78.3% | −0.4 |
| Q1 FY2026 | Apr 4, 2026 | 76.2% | −2.7 |
| Q4 FY2025 | Jan 3, 2026 | 78.2% | −3.8 |
| Q3 FY2025 | Sep 27, 2025 | 77.2% | −3.2 |
| Q2 FY2025 | Jun 28, 2025 | 78.7% | −2.3 |
| Q1 FY2025 | Mar 29, 2025 | 79.0% | −2.1 |
| Q4 FY2024 | Dec 28, 2024 | 82.0% | +1.1 |
| Q3 FY2024 | Sep 28, 2024 | 80.4% | +0.3 |
| Q2 FY2024 | Jun 29, 2024 | 81.1% | −0.8 |
| Q1 FY2024 | Mar 30, 2024 | 81.1% | +0.6 |
| Q4 FY2023 | Dec 30, 2023 | 80.9% | +1.2 |
| Q3 FY2023 | Sep 30, 2023 | 80.1% | +0.0 |
| Q2 FY2023 | Jul 1, 2023 | 81.8% | +0.5 |
| Q1 FY2023 | Apr 1, 2023 | 80.5% | −0.7 |
| Q4 FY2022 | Dec 31, 2022 | 79.6% | −0.7 |
| Q3 FY2022 | Oct 1, 2022 | 80.0% | −1.5 |
| Q2 FY2022 | Jul 2, 2022 | 81.3% | −1.8 |
| Q1 FY2022 | Apr 2, 2022 | 81.2% | −0.1 |
| Q4 FY2021 | Jan 1, 2022 | 80.4% | −0.6 |
| Q3 FY2021 | Oct 2, 2021 | 81.5% | +0.4 |
| Q2 FY2021 | Jul 3, 2021 | 83.1% | +1.5 |
| Q1 FY2021 | Apr 3, 2021 | 81.3% | −1.4 |
| Q4 FY2020 | Jan 2, 2021 | 81.0% | −1.6 |
| Q3 FY2020 | Sep 26, 2020 | 81.1% | −0.5 |
| Q2 FY2020 | Jun 27, 2020 | 81.6% | −0.2 |
| Q1 FY2020 | Mar 28, 2020 | 82.7% | −0.5 |
| Q4 FY2019 | Dec 28, 2019 | 82.6% | −0.9 |
| Q3 FY2019 | Sep 28, 2019 | 81.7% | −0.9 |
| Q2 FY2019 | Jun 29, 2019 | 81.8% | −1.6 |
| Q1 FY2019 | Mar 30, 2019 | 83.2% | +0.1 |
| Q4 FY2018 | Dec 29, 2018 | 83.5% | +0.2 |
| Q3 FY2018 | Sep 29, 2018 | 82.5% | +0.5 |
| Q2 FY2018 | Jun 30, 2018 | 83.4% | +0.5 |
| Q1 FY2018 | Mar 31, 2018 | 83.1% | −0.2 |
| Q4 FY2017 | Dec 30, 2017 | 83.3% | +1.6 |
| Q3 FY2017 | Sep 30, 2017 | 82.0% | – |
| Q2 FY2017 | Jul 1, 2017 | 82.9% | – |
| Q1 FY2017 | Apr 1, 2017 | 83.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 81.7% | – |
See a number that looks wrong?